| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 1692-1700, Copyright © 1995 by Endocrine Society
ARTICLES |
CV Hedvat and SG Irving
Department of Pathology, Georgetown University School of Medicine, Washington, DC 20007, USA.
The nuclear (steroid/thyroid/retinoid) receptor superfamily is a set of evolutionarily related ligand-inducible regulators of transcription. One subgroup within this family has been termed the orphan receptors because the potential ligands required for their activity have not been identified. We have cloned a novel orphan receptor, MINOR, which is mitogen inducible in a variety of cell types. Unlike NGFI-B/Nur77, another mitogen-inducible orphan receptor, MINOR gene expression is inhibited in Jurkat cells by the immunosuppressant cyclosporin A, suggesting that it is regulated by distinct second messenger pathways. The conservation of the DNA-binding domain between MINOR and other orphan receptors is reflected in the fact that they are able to bind to the same sequence, AAAG-GTCA [termed the NBRE (NGFI-B response element)]. The marked divergence in other domains, particularly the N- terminal putative transactivation domain, may result in qualitative or quantitative differences in other functions among these proteins. One of these differences may be the apparent squelching of peak levels of MINOR-mediated transcription by supraoptimal levels of MINOR expression, an effect not obtained with NGFI-B/Nur77. When MINOR i coexpressed with submaximal levels of NGFI-B/Nur77, synergistic or additive levels of reporter gene expression are obtained. However, at maximal levels of NGFI-B/Nur77 expression, MINOR antagonizes the level of reporter gene expression in a dose-dependent fashion. These cooperative/competitive interactions, together with the nonidentical expression patterns of MINOR and NGFI-B/Nur77, suggest complexity in the regulation of genes responsive to orphan receptors which bind to the NBRE.
This article has been cited by other articles:
![]() |
Y. Fu, L. Luo, N. Luo, X. Zhu, and W. T. Garvey NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport System: POTENTIAL ROLE IN INSULIN RESISTANCE J. Biol. Chem., October 26, 2007; 282(43): 31525 - 31533. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al. International Union of Pharmacology. LXVI. Orphan Nuclear Receptors Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zeng, L. Qin, D. Zhao, X. Tan, E. J. Manseau, M. Van Hoang, D. R. Senger, L. F. Brown, J. A. Nagy, and H. F. Dvorak Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity J. Exp. Med., March 20, 2006; 203(3): 719 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Yeo, Y.-G. Yoo, H.-S. Choi, Y. K. Pak, and M.-O. Lee Negative Cross-Talk between Nur77 and Small Heterodimer Partner and Its Role in Apoptotic Cell Death of Hepatoma Cells Mol. Endocrinol., April 1, 2005; 19(4): 950 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cao, W. Liu, F. Lin, H. Li, S. K. Kolluri, B. Lin, Y.-h. Han, M. I. Dawson, and X.-k. Zhang Retinoid X Receptor Regulates Nur77/Thyroid Hormone Receptor 3-Dependent Apoptosis by Modulating Its Nuclear Export and Mitochondrial Targeting Mol. Cell. Biol., November 15, 2004; 24(22): 9705 - 9725. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Shin, B.-H. Lee, M. G. Yeo, S.-H. Oh, J.-D. Park, K.-K. Park, J.-H. Chung, C.-K. Moon, and M.-O. Lee Induction of orphan nuclear receptor Nur77 gene expression and its role in cadmium-induced apoptosis in lung Carcinogenesis, August 1, 2004; 25(8): 1467 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sjogren, J. M. Meis-Kindblom, C. Orndal, P. Bergh, K. Ptaszynski, P. Aman, L.-G. Kindblom, and G. Stenman Studies on the Molecular Pathogenesis of Extraskeletal Myxoid Chondrosarcoma--Cytogenetic, Molecular Genetic, and cDNA Microarray Analyses Am. J. Pathol., March 1, 2003; 162(3): 781 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Laflamme, C. Filion, J. A. Bridge, M. Ladanyi, M. B. Goldring, and Y. Labelle The Homeotic Protein Six3 Is a Coactivator of the Nuclear Receptor NOR-1 and a Corepressor of the Fusion Protein EWS/NOR-1 in Human Extraskeletal Myxoid Chondrosarcomas Cancer Res., January 15, 2003; 63(2): 449 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez-Gonzalez, J. Rius, A. Castello, C. Cases-Langhoff, and L. Badimon Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation Circ. Res., January 10, 2003; 92(1): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ponnio, Q. Burton, F. A. Pereira, D. K. Wu, and O. M. Conneely The Nuclear Receptor Nor-1 Is Essential for Proliferation of the Semicircular Canals of the Mouse Inner Ear Mol. Cell. Biol., February 1, 2002; 22(3): 935 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ohkura, H. Yaguchi, T. Tsukada, and K. Yamaguchi The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing J. Biol. Chem., January 4, 2002; 277(1): 535 - 543. [Abstract] [Full Text] |
||||
![]() |
V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text] |
||||
![]() |
Y. Ueda, S. Bandoh, J. Fujita, M. Sato, Y. Yamaji, and J. Takahara Expression of Nerve Growth Factor-Induced Clone B Subfamily and Pro-opiomelanocortin Gene in Lung Cancer Cell Lines Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1319 - 1325. [Abstract] [Full Text] |
||||
![]() |
E. P. Murphy and O. M. Conneely Neuroendocrine Regulation of the Hypothalamic Pituitary Adrenal Axis by the nurr1/nur77 Subfamily of Nuclear Receptors Mol. Endocrinol., January 1, 1997; 11(1): 39 - 47. [Abstract] [Full Text] |
||||
![]() |
C. J. M. de Vries, T. A. E. van Achterberg, A. J. G. Horrevoets, J. W. ten Cate, and H. Pannekoek Differential Display Identification of 40 Genes with Altered Expression in Activated Human Smooth Muscle Cells. LOCAL EXPRESSION IN ATHEROSCLEROTIC LESIONS OF smags, SMOOTH MUSCLE ACTIVATION-SPECIFIC GENES J. Biol. Chem., July 28, 2000; 275(31): 23939 - 23947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |